Pharmaceutical Intermediates Market to Witness Sales Slump in Near Term Due to COVID-19; Long-term Outlook Remains Positive

FMI has compiled a study on the pharmaceutical intermediates market, which offers an analysis and forecast of the Pharmaceutical Intermediates market in its publication titled ‘Pharmaceutical Intermediates Market: Global Industry Analysis 2014 – 2018 and Opportunity Assessment 2019 – 2029.’ This report on the Pharmaceutical intermediates market covers some of the key influencing factors on the demand and supply of Pharmaceutical Intermediates over the next several years. An in-depth review of the growth drivers, potential challenges, unique trends, and opportunities for the market participants is expected to equip readers to fully comprehend the overall landscape of the Pharmaceutical Intermediates market.

The report on the pharmaceutical intermediates market also covers an analysis of the key regions and countries of particular interest, which are estimated to become frontrunners or remain laggards over the forecast period. The report covers a historical analysis of the market from 2014 to 2018, and provides forecasts from 2019 to 2029 in terms of revenue in US$.

For more insights into the Market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-4515

Pharmaceutical intermediates are the raw materials used to manufacture active pharmaceutical ingredients for the final drug formulation. There are different types of pharmaceutical intermediates and demand of each type of the pharmaceutical intermediates is high due to increasing pharmaceutical and biopharmaceutical production.

This report on the pharmaceutical intermediates market has been broken down into different chapters to enhance clarity and provide context. A brief executive summary at the beginning of the report consists of some of the key findings of the study on the pharmaceutical intermediates market, as well as market estimates and growth rates for important segments. The following chapter presents the definitions and scope of the study, as well as the coverage in terms of the way in which the pharmaceutical intermediates market is structured.

Subsequently, the chapter on the market background contains relevant economic indicators, such as per capita healthcare spending and increase in cancer cases, which elaborate the dynamics impacting the pharmaceutical intermediates market, as well as provides an explanation of the factors considered important to develop forecasts and estimates. The following chapters dive deep into the global pharmaceutical intermediates market, covering detailed information based on product type, application and end user. The next set of chapters provide a region-wise analysis and forecasts of the pharmaceutical intermediates market, which cover the vital aspects of the market in North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East and Africa.

A dashboard view of some of the key companies operating in the pharmaceutical intermediates market in terms of their offerings, regional presence, and other metrics is a precursor to the detailed profiles of these participants, which include their financial information, strategy overview, and products offered, SWOT analysis as well as analyst commentary. Some of the key players analyzed in the Pharmaceutical Intermediates market report include Chiracon GmbH, Aceto Corporation, Midas Pharma GmbH, BASF SE, Codexis, Inc., A.R. Life Sciences Private Limited, Dishman Group, ZCL Chemicals Ltd., Pfizer, Inc., Arkema Inc and Cambrex Corporation among others.

To develop the estimates for the pharmaceutical intermediates market, the global adoption/consumption of pharmaceutical intermediates was taken into account, which was followed by tracking key players and their product offering globally. This is then cross-referenced with the revenue generated from the sales of pharmaceutical intermediates for top companies globally.

Our team of analysts reviews and interpret data from a variety of sources. The data attributed to ‘FMI’ is derived by using a combination of various approaches, which are then consolidated, interpreted, and extrapolated by FMI analysts. Data is sourced from government statistics, trade associations, company annual reports, investor presentations, press articles & directories, technical publications, and online databases, which are cross-referenced with FMI’s reports and internal repository of data to filter and validate the collected information.

The intelligence gathered from desk research is supplemented by extensive interviews with selected key expert participants across the value chain not only to gain information specific to their role and operations, but also to obtain their perspective and insights of the issues impacting the pharmaceutical intermediates market.

Table Of Content

1. Executive Summary

       1.1. Global Market Outlook

       1.2. Demand Side Trends

       1.3. Supply Side Trends

       1.4. Analysis and Recommendations

2. Market Overview

       2.1. Market Coverage / Taxonomy

       2.2. Market Definition / Scope / Limitations

3. Key Market Trends

       3.1. Key Trends Impacting the Market

       3.2. Product Innovation / Development Trends

4. Key Success Factors

       4.1. Product Adoption / Usage Analysis

       4.2. Product USPs / Features

       4.3. Strategic Promotional Activities, By Key Manufacturers

5. Global Pharmaceutical Intermediates Market Demand (in Value or Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029

       5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018

       5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029

                5.2.1. Y-o-Y Growth Trend Analysis

                5.2.2. Absolute $ Opportunity Analysis

6. Market Background

       6.1. Macro-Economic Factors

                6.1.1. Increasing Healthcare R & D Spending

                6.1.2. Emergence of Academia as the Primary Organisation for Carrying Out Basic Research

       6.2. Forecast Factors – Relevance & Impact

                6.2.1. Prevalence of Chronic Diseases

                6.2.2. Increased Government Focus on Generic Drugs

                6.2.3. Growing Demand for Biologics and Specialty Drugs

                6.2.4. Production Capacity Growth

                6.2.5. Top Companies Historic Average Growth

       6.3. Market Dynamics

                6.3.1. Drivers

                6.3.2. Restraints

                6.3.3. Opportunity Analysis

Request To Browse Full Table of Content, Figure And Tables @ https://www.futuremarketinsights.com/toc/rep-gb-4515

Global Pharmaceutical Intermediates Market: Segmentation

Analysis by Product Type

• Chemical Intermediates
  
• Bulk Drug Intermediates
  • Chiral Intermediates
    
  • Achiral Intermediates
    
• Custom Intermediates
  

Analysis by Category

• Branded Drug Intermediates
  
• Generic Drug Intermediates
  

Analysis by Application/Drug Type

• Analgesics
  
• Anti-Infective Drugs
  
• Cardiovascular Drugs
  
• Oral Antidiabetic Drugs
  
• Antimicrobial Drugs
  
• Others
  

Analysis by End User

• Biotech & Pharma Companies
  
• Research Laboratories
  
• CMOs/CROs
  

Analysis by Region

• North America
  
• Latin America
  
• Europe
  
• East Asia
  
• South Asia
  
• Oceania
  
• Middle East & Africa
  

About FMI

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact

Mr. Abhishek Budholiya
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com